the clinical effects of a new cardioselective beta-adrenergic blocking drug , acebutolol hydrochloride ( sectral ) , were studied in 18 patients with angina pectoris , using graded treadmill testing according to a modified bruce protocol .
C0543447
acebutolol hydrochloride
C0002962
angina